research Hair whitening in a patient with psoriasis on adalimumab reversed after switching to ixekizumab
This case report describes a 40-year-old man whose vitiligo and psoriasis responded favorably to ixekizumab after experiencing vitiligo onset and psoriasis relapse during adalimumab treatment.
